Group 1 - GT Biopharma (NASDAQ:GTBP) stock is experiencing significant trading activity, with over 10.6 million shares changing hands, far exceeding its daily average of approximately 10,000 shares [1][2] - The company's market capitalization is reported at $4.308 million, categorizing it as a penny stock, which is characterized by low trading volume [2] - As of Monday morning, GTBP stock has surged by 143%, indicating a substantial increase in value [3] Group 2 - The rise in GTBP stock is occurring without any accompanying news, press releases, or analyst coverage, suggesting that the movement may not be based on fundamental developments [2][3] - The penny stock status of GTBP raises concerns about potential market manipulation, as such stocks can be susceptible to traders who artificially inflate prices before selling for profit [3]
Why Is GT Biopharma (GTBP) Stock Up 143% Today?